Bringing Optimised COVID-19 vaccine Schedules To Immunocompromised populations (BOOST IC) an adaptive randomised controlled clinical trial (NCT05556720)
BOOST-IC
This trial is No longer recruiting
Registration number NCT05556720
Program & service
This trial is being run with the Infectious Diseases service, and as part of the Infectious Diseases program.
Trial phase
Phase 3
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Professor James McMahon
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR